本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc Series A P

7.89
-0.5099-6.07%
盘后7.890.00000.00%13:30 EDT
成交量:4,764.00
成交额:3.78万
市值:2,704.02万
市盈率:-2.93
高:8.40
开:8.40
低:7.69
收:8.40
数据加载中...
2020/05/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/19

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/11

重要事件披露

Current report, items 2.02 and 9.01
2020/05/11

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/04/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/23

重要事件披露

8-K - Current report
2020/03/16

重要事件披露

Current report, items 2.02 and 9.01
2020/03/16

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/27

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/31

重要事件披露

Current report, item 5.02
2019/11/26

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/26

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/22

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]